|
|||||
|
|
The rheumatoid arthritis susceptibility polymorphism PTPN22 C1858T is not associated with leflunomide response or toxicity |
|
| Authors: | A. M. Hopkins BPharm C. E. O'Doherty MPharm PhD D. J. R. Foster BSc PhD V. Suppiah BSc PhD R. N. Upton BSc PhD L. D. Spargo BSc L. G. Cleland FRACP PhD S. M. Proudman FRACP M. D. Wiese Mas. Clin. Pharm. BPharm PhD |
| Affiliation: | 1. Sansom Institute for Health Research and School of Pharmacy and Medical Sciences, University of South Australia, , Adelaide, SA, Australia;2. Department of Rheumatology, Royal Adelaide Hospital, , Adelaide, SA, Australia;3. Discipline of Medicine, Adelaide University, , Adelaide, SA, Australia |
| Abstract: | |
| Keywords: | leflunomide pharmacogenomics polymorphism PTPN22 rheumatoid arthritis |